Publication number: 20250388541
Abstract: Compounds, and pharmaceutically acceptable salts thereof, useful as inhibitors of sodium channels are provided. Also provided are pharmaceutical compositions comprising the compounds or pharmaceutically acceptable salts and methods of using the compounds, pharmaceutically acceptable salts, and pharmaceutical compositions in the treatment of various disorders, including pain.
Type:
Application
Filed:
April 21, 2023
Publication date:
December 25, 2025
Applicant:
VERTEX PHARMACEUTICALS INCORPORATED
Inventors:
Mark Thomas MILLER, Carl Victor VOGEL, Thomas Aaron BEDELL, Dennis James HURLEY, Timothy Donald NEUBERT, Elamprakash NESAN SAVARIAR, Urvi PATEL, Sara Sabina HADIDA RUAH, Jason McCARTNEY, Jinglan ZHOU, Robert Martin DEMORET, Roman Askatovich VALIULIN, Alexander Frederick KINTZER, Peter WEBB, David Robert SLOCHOWER, Kathleen AERTGEERTS, Elizabeth Mary BECK, Ronald Marcellus Alphonsus KNEGTEL, Ewa Iwona CHUDYK, Joanne Louise PINDER, Anton V. GULEVICH, Yoshihiro ISHIHARA, Joe A. TRAN